Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylcysteine and Vitamin E in Mild Psoriasis Vulgaris
NCT05906498Phase 3Unknown
- Sponsor
- Badr University in Cairo
- Start
- Dec 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in Psoriasis vulgaris (PV), sponsored by Badr University in Cairo. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT05906498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05906498.